Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
AC144573.1		ENSG00000285880	"ADRB3-GOT1L1 readthrough"		8	37934340-37965953	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.9;Enteroendocrine cells: 1.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												HPA061969	Uncertain					NA	NA					"Cluster 65: Breast cancer - Unknown function"	"Cluster 57: Early spermatids - Flagellum & Golgi organization"			"HPA061969: AB_2732674"																	
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442357	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.6;brain: 101.4;lymphoid tissue: 54.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.2;Gastric mucus-secreting cells: 1.8;Plasma cells: 10.5;T-cells: 3.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"basal ganglia: 101.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 44.1;Myeloma: 41.0"	"Kidney - Endothelial cells"	"Region enriched"	"Detected in many"	9	"basal ganglia: 399.8"	"Region enriched"	"Detected in many"	50	"basal ganglia: 142.2"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"
ADRB3		ENSG00000188778	"Adrenoceptor beta 3"	P13945	8	37962990-37966599	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;ovary: 11.7"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 1.0;Langerhans cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"medulla oblongata: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	135	"Bone cancer: 19.1"	"Breast - Adipocytes (Breast), Prostate - Fibroblasts"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA061969	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 14: Bone cancer - Transcription"	"Cluster 53: Connective tissue cells - ECM organization"			"HPA061969: AB_2732674"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.64e-3)"	"unprognostic (5.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.07e-1)"		"unprognostic (1.14e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.10e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.06e-3)"
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0;choroid plexus: 6.4;fallopian tube: 13.9"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 60.6;Respiratory ciliated cells: 71.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Kidney - Endothelial cells, Lung - Respiratory ciliated cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 56: Ciliated cells - Cilium assembly"			"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24256335-24362412	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 53.4;retina: 17.7"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 154.9;Horizontal cells: 59.0;Inhibitory neurons: 104.9"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	41	"Bone cancer: 4.0"	"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling"	"Cluster 38: Neurons - Neuronal signaling"			"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"		
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 320.6"	"Cell type enriched"	"Detected in some"	4	"Cone photoreceptor cells: 212.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.8;monocytes: 1.4"	"Low cancer specificity"	"Detected in all"			"Colon - Colon enteroendocrine cells"	"Region enhanced"	"Detected in all"		"cerebellum: 430.7"	"Group enriched"	"Detected in all"	4	"basal ganglia: 49.7;cerebellum: 119.6"	"CAB002138, HPA023099, HPA056734"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 44: Photoreceptor cells - Visual perception"	Vesicles		"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 236.9;pituitary gland: 167.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 132.9;Excitatory neurons: 71.5;Horizontal cells: 97.4;Inhibitory neurons: 125.3"	"Cancer enriched"	"Detected in some"	4	"pancreatic cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 2.3"	"Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Thyroid - Parafollicular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 35: Bipolar cells - Visual perception"			"HPA042283: AB_10794417"	"unprognostic (1.43e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.32e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.23e-2)"	"unprognostic (4.19e-10)"	"unprognostic (8.04e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.63e-1)"
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49667942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 13.0;placenta: 5.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 1.4;Horizontal cells: 3.8;Late spermatids: 1.5;Smooth muscle cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Bone cancer: 4.0;Neuroblastoma: 5.7"	"Colon - Colon enteroendocrine cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 20.6"	"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 56: Neurons - Neuronal signaling"	"Cluster 53: Connective tissue cells - ECM organization"			"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"		
CRACDL	"C2orf55, KIAA1211L, MGC42367"	ENSG00000196872	"CRACD like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 31.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.7;Endometrial ciliated cells: 74.8;Excitatory neurons: 157.6;Respiratory ciliated cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 20.0;cerebral cortex: 30.8;hippocampal formation: 29.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Endothelial cells, Liver - Vascular Endothelial cells"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No				"Cluster 68: Epididymis - Unknown function"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 38: Neurons - Neuronal signaling"	"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;testis: 2.8"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 67.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"Neuroblastoma: 1.2"	"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040685, HPA053234"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 57: Early spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA040685: AB_2732487, HPA053234: "	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;endometrium 1: 1.4;retina: 2.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 38.5;Inhibitory neurons: 88.2;Oligodendrocyte precursor cells: 47.7;Rod photoreceptor cells: 20.1"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"Neuroblastoma: 29.1"	"Pancreas - Beta cells, Skin - Fibroblast_1"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 74.0"	"Region enriched"	"Detected in all"	4	"olfactory bulb: 68.6"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 21: Neuroblastoma - Neuronal signaling"	"Cluster 37: Neurons - Neuronal signaling"	Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123935720	"Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;choroid plexus: 2.6;fallopian tube: 4.1;testis: 3.0"	"Group enriched"	"Detected in many"	8	"Early spermatids: 30.3;Endometrial ciliated cells: 87.1;Late spermatids: 63.4;Respiratory ciliated cells: 86.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Respiratory ciliated cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039066	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: DU4475 - Unknown function"	"Cluster 56: Ciliated cells - Cilium assembly"			"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520988	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.9;choroid plexus: 28.3;fallopian tube: 33.9;pituitary gland: 9.5;testis: 33.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 37.9;Endometrial ciliated cells: 49.1;Late spermatids: 32.9;Respiratory ciliated cells: 110.2;Spermatocytes: 46.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"breast cancer: 1.5"	"Breast - Breast glandular cells, Lung - Respiratory ciliated cells, Pancreas - Alpha cells, Pancreas - Beta cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021649, HPA021843"	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 56: Ciliated cells - Cilium assembly"			"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"
DNER	"bet, UNQ26"	ENSG00000187957	"Delta/notch like EGF repeat containing"	Q8NFT8	2	229357629-229714555	"Cancer-related genes, Predicted membrane proteins"	"Notch signaling pathway"	"Activator, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 73.0;brain: 147.5;choroid plexus: 143.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.3;Horizontal cells: 169.8;Inhibitory neurons: 325.0;Oligodendrocyte precursor cells: 417.3;Oligodendrocytes: 233.8;Serous glandular cells: 199.6"	"Cancer enriched"	"Detected in many"	32	"glioma: 73.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Respiratory ciliated cells, Skin - Eccrine sweat gland cells, Thyroid - Parafollicular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017320	Enhanced					NA	NA		7900000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 32: Neurons - Synaptic function"			"HPA017320: AB_1847808"	"unprognostic (4.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (2.59e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.13e-3)"
FGF11	"FHF3, FLJ16061, MGC102953, MGC45269"	ENSG00000161958	"Fibroblast growth factor 11"	Q92914	17	7438273-7444937	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 31.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Basal squamous epithelial cells: 2.9;Horizontal cells: 2.6;Microglial cells: 2.7;Oligodendrocyte precursor cells: 5.3;Suprabasal keratinocytes: 3.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells"	"Low region specificity"	"Detected in all"							"HPA066605, HPA075188"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 63: Astrocytes - Nervous system maintenance"	Centrosome		"HPA066605: AB_2685693, HPA075188: AB_2732283"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-4)"	"unprognostic (9.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.00e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.90e-3)"	"unprognostic (4.97e-3)"
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.9;Alveolar cells type 1: 31.5;Astrocytes: 107.5;Endometrial stromal cells: 39.3;Oligodendrocyte precursor cells: 40.4;Schwann cells: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 63: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11689264-11885685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 99.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.9;Inhibitory neurons: 117.2;Oligodendrocyte precursor cells: 56.3;Salivary duct cells: 37.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 99.0"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"basal ganglia: 164.1"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Enzymes"	"Cluster 37: Neurons - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"
GNG12		ENSG00000172380	"G protein subunit gamma 12"	Q9UBI6	1	67701475-67833467	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 208.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"							"HPA057790, HPA062208"	Enhanced	Supported	Approved	Mitochondria		NA	NA		550000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 74: Pancreatic cells - Mixed function"	Mitochondria		"HPA057790: AB_2683527, HPA062208: AB_2684711"	"unprognostic (5.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.46e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.46e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-3)"
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702694	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"brain: 360.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.9;dendritic cells: 129.9;Horizontal cells: 92.9;Muller glia cells: 87.2;Oligodendrocyte precursor cells: 98.2;Oligodendrocytes: 194.6;Plasma cells: 132.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9;melanoma: 20.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0"	"Group enriched"	"Detected in many"	4	"B-cells: 57.2;dendritic cells: 48.0"	"Group enriched"	"Detected in many"	6	"Leukemia: 14.7;lymphoma: 17.3;Myeloma: 27.2;skin cancer: 8.7"	"Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skin - Eccrine sweat gland cells, Testis - Sertoli cells"	"Region enriched"	"Detected in all"	6	"basal ganglia: 1277.2"					HPA057790	Supported	Supported				NA	NA		72000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 490.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.8;Late spermatids: 283.3;Oligodendrocytes: 161.4;Sertoli cells: 91.2"	"Cancer enhanced"	"Detected in all"		"glioma: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Colon - Endothelial cells, Pancreas - Ductal cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 36: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511746-120988906	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 80.3;Excitatory neurons: 113.9;Inhibitory neurons: 42.6;Oligodendrocyte precursor cells: 187.7;Oligodendrocytes: 102.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"Myeloma: 3.8"	"Lung - Fibroblast_1, Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 38: Neurons - Neuronal signaling"			"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137139154-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 186.7"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 130.7;Horizontal cells: 127.5;Inhibitory neurons: 131.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.8"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 186.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 4.5"	"Colon - Colon enteroendocrine cells, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: Neuroblastoma - Neuronal signaling"	"Cluster 37: Neurons - Neuronal signaling"			"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 8.5;heart muscle: 8.4;testis: 7.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 16.9;Late spermatids: 54.6"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 1.6;testis cancer: 1.2"	"Lung - Respiratory ciliated cells, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved					NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 51: Late spermatids - Spermatogenesis"			"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"
HTR6	"5-HT6, 5-HT6R"	ENSG00000158748	"5-hydroxytryptamine receptor 6"	P50406	1	19664875-19680966	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 9.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.6;Spermatogonia: 1.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.7;cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 2.2;Rhabdoid: 3.1"		"Low region specificity"	"Detected in many"							HPA068165	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 38: Neurons - Neuronal signaling"			"HPA068165: "	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-5)"	"unprognostic (1.38e-4)"	"unprognostic (2.69e-2)"		"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.33e-3)"	"unprognostic (8.63e-2)"	"unprognostic (5.47e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.02e-1)"
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273175-120750337	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 47.3"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 680.6;Inhibitory neurons: 1045.4;Oligodendrocyte precursor cells: 1870.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.7"	"Thyroid - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 37: Neurons - Neuronal signaling"			"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148510-19535642	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.0;pituitary gland: 10.7"	"Group enriched"	"Detected in some"	61	"Oligodendrocyte precursor cells: 317.7;Oligodendrocytes: 933.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.4"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.3;Gallbladder cancer: 3.9;Gastric cancer: 1.1;lung cancer: 1.2;Neuroblastoma: 2.4;prostate cancer: 1.3"	"Colon - Enteric glia cells, Skin - Outer root sheath cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 8: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.5;Endometrial ciliated cells: 28.6;Plasma cells: 41.5;Skeletal myocytes: 86.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	11	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Group enriched"	"Detected in some"	6	"lymphoma: 19.9;Myeloma: 34.8"	"Adipose subcutaneous - Smooth muscle cells, Colon - Enteric glia cells, Heart muscle - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017990, HPA057127"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 63: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA017990: AB_2669730, HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.6;retina: 29.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 197.5;Horizontal cells: 51.3;Inhibitory neurons: 38.0;Plasma cells: 28.3;Theca cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"plasmacytoid DC: 141.3"	"Lineage enriched"	"Detected in many"	31	"dendritic cells: 141.3"	"Group enriched"	"Detected in some"	7	"Leukemia: 57.0;Myeloma: 88.1;Neuroblastoma: 32.3"	"Colon - Enteric glia cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"	Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266165-139280225	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 228.0;retina: 116.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 126.3;Granulosa cells: 111.5;Horizontal cells: 116.6;Muller glia cells: 454.9;Theca cells: 338.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"Rhabdoid: 45.2"	"Adipose visceral - Mesothelial cells, Breast - Breast myoepithelial cells, Thyroid - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 68: Muller glia cells - Visual perception"	Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 46.2;Salivary duct cells: 22.5;Skeletal myocytes: 8.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Sarcoma: 3.8"	"Adipose visceral - Smooth muscle cells, Colon - Colon enteroendocrine cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Sarcoma - Muscle contraction"	"Cluster 32: Neurons - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 10.7;ovary: 7.4"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 117.9;Inhibitory neurons: 340.7;Oligodendrocyte precursor cells: 166.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Bone cancer: 1.1"	"Adipose visceral - Smooth muscle cells, Skin - Outer root sheath cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077495	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Rabdoid cancer - Embryonic development"	"Cluster 37: Neurons - Neuronal signaling"			"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489081-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 28.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 4.7;testis cancer: 7.4"	"Lung - Fibroblast_1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA076140"	Supported		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HUVEC & TIME - Signal transduction"		"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258745-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.7;pituitary gland: 84.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 69.5;Inhibitory neurons: 33.2;Squamous epithelial cells: 27.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Lung - Alveolar cells type 2, Prostate - Urothelial cells, Skin - Sebaceous gland cells, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 206.6"	HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 29: TT & NCI-H1385 - Synaptic signal transduction"	"Cluster 35: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831096-48835610	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 642.6;pituitary gland: 1243.7"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 4508.3;Proximal tubular cells: 1361.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 2.4;memory CD4 T-cell: 5.0;memory CD8 T-cell: 4.9;naive CD4 T-cell: 2.0;naive CD8 T-cell: 6.4;T-reg: 1.8"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells, Thyroid - Parafollicular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		3300000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 29: TT & NCI-H1385 - Synaptic signal transduction"	"Cluster 55: Endocrine cells - Hormone signaling"	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.3;Hofbauer cells: 8.0;Horizontal cells: 11.5;Inhibitory neurons: 10.0;Kupffer cells: 8.7;Macrophages: 9.6;Smooth muscle cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Bone cancer: 8.7;Leukemia: 8.5;lymphoma: 7.0;Myeloma: 2.7"	"Breast - Adipocytes (Breast), Pancreas - Endothelial cells"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: Bone cancer - Transcription"	"Cluster 72: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 47.0"	"Group enriched"	"Detected in some"	47	"Early spermatids: 39.8;Late spermatids: 122.5"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	13	"Bone cancer: 4.2"	"Testis - Early spermatids, Testis - Late spermatids"	"Group enriched"	"Detected in many"	4	"basal ganglia: 152.2;hypothalamus: 60.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 132.2"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling"	"Cluster 6: Late spermatids - Spermatogenesis"			"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"		
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 22.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"medulla oblongata: 22.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Group enriched"	"Detected in some"	58	"hypothalamus: 11.3;pons and medulla: 21.5"	"Region enriched"	"Detected in single"	14	"medulla oblongata: 5.5"	HPA014976	Uncertain				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 73: Prostatic glandular cells - Transcription"			"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"							
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 234.3;pituitary gland: 182.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 55.8;Cone photoreceptor cells: 65.5;Excitatory neurons: 44.0;Horizontal cells: 103.8;Inhibitory neurons: 47.0;Pancreatic endocrine cells: 82.4;Rod photoreceptor cells: 29.4"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 40.3;thyroid cancer: 37.3"	"Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells, Thyroid - Parafollicular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		38000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 29: TT & NCI-H1385 - Synaptic signal transduction"	"Cluster 9: Neurons - Nervous system development"	"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2599.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 30.7"	"Adipose visceral - Mesothelial cells, Colon - Enteric glia cells, Prostate - Urothelial cells, Skin - Keratinocyte (other), Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: Skin cancer - Membrane components"	"Cluster 10: Neurons & Oligodendrocytes - Nervous system development"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"
RTP5	"C2orf85, CXXC11, FLJ33590, Z3CXXC5"	ENSG00000188011	"Receptor transporter protein 5 (putative)"	Q14D33	2	241869600-241873823	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 4.0;Late spermatids: 6.1;Oligodendrocyte precursor cells: 16.8"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Prostate - T-cells"					"Low region specificity"	"Detected in all"			HPA050902	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 10: Neurons & Oligodendrocytes - Nervous system development"			"HPA050902: AB_2681268"	"unprognostic (3.26e-2)"	"unprognostic (5.38e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.40e-4)"	"unprognostic (8.68e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.34e-4)"	"unprognostic (3.30e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.91e-1)"	"unprognostic (9.08e-8)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.72e-2)"
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433691-38587564	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1618.9"	"Cell type enriched"	"Detected in many"	9	"Skeletal myocytes: 452.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 3.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"		"Low region specificity"	"Detected in single"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		46000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Sarcoma - Muscle contraction"	"Cluster 27: Skeletal myocytes - Muscle contraction"	"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Group enriched"	"Detected in many"	15	"Glandular and luminal cells: 122.4;granulocytes: 430.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Group enriched"	"Detected in some"	5	"Leukemia: 10.4;Neuroblastoma: 6.6"	"Adipose subcutaneous - Mast cells, Adipose visceral - Mast cells, Colon - Mast cells, Lung - Mast cells, Skin - Langerhans cells, Testis - Spermatogonia"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 46: Granulocytes - Mast cell degranulation"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392794-1445440	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 60.6"	"Cell type enhanced"	"Detected in single"		"Serous glandular cells: 2.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	26	"midbrain: 60.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"Kidney cancer: 3.3"	"Adipose visceral - Mesothelial cells"	"Group enriched"	"Detected in many"	8	"midbrain: 80.6;thalamus: 29.0"	"Region enriched"	"Detected in some"	152	"midbrain: 302.6"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 68: Kidney - Mixed function"	"Cluster 61: Non-specific - Transcription"	Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"
SOX21	SOX25	ENSG00000125285	"SRY-box transcription factor 21"	Q9Y651	13	94709622-94712545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.8;esophagus: 10.3;skin 1: 15.9;stomach 1: 35.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 23.7;Basal squamous epithelial cells: 21.3;Gastric mucus-secreting cells: 62.0;Oligodendrocyte precursor cells: 16.4;Squamous epithelial cells: 62.3"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 13.4"	"Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048337, HPA064084"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 22: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA048337: AB_2732547, HPA064084: AB_2685187"	"unprognostic (3.33e-1)"	"prognostic favorable (7.60e-4)"		"unprognostic (7.96e-2)"	"prognostic favorable (8.79e-5)"	"unprognostic (1.54e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.02e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471618-83582303	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 969.7;Granulosa cells: 1101.8;Kupffer cells: 1041.7;Macrophages: 573.9;Oligodendrocyte precursor cells: 1575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 240.0;myeloid DC: 88.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 88.9;monocytes: 240.0"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 172.8"	"Heart muscle - Fibroblasts, Prostate - Fibroblasts, Stomach - Fibroblasts, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 68: Kidney - Mixed function"	"Cluster 33: Macrophages - Degranulation"	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859805-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 10.8;Schwann cells: 49.9;Sertoli cells: 52.5;Smooth muscle cells: 16.8;Spermatocytes: 13.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 72: Smooth muscle cells - ECM organization"			"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"